rs139278612

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_ModerateBS1BS2

The NM_152618.3(BBS12):​c.1859A>G​(p.Gln620Arg) variant causes a missense change. The variant allele was found at a frequency of 0.000554 in 1,614,064 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q620E) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00046 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00056 ( 2 hom. )

Consequence

BBS12
NM_152618.3 missense

Scores

5
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:10B:2

Conservation

PhyloP100: 4.14

Publications

7 publications found
Variant links:
Genes affected
BBS12 (HGNC:26648): (Bardet-Biedl syndrome 12) The protein encoded by this gene is part of a complex that is involved in membrane trafficking. The encoded protein is a molecular chaperone that aids in protein folding upon ATP hydrolysis. This protein also plays a role in adipocyte differentiation. Defects in this gene are a cause of Bardet-Biedl syndrome type 12. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, May 2010]
BBS12 Gene-Disease associations (from GenCC):
  • Bardet-Biedl syndrome 12
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Myriad Women’s Health, G2P, Ambry Genetics
  • BBS12-related ciliopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Bardet-Biedl syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.10503021).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00046 (70/152214) while in subpopulation NFE AF = 0.000897 (61/68038). AF 95% confidence interval is 0.000716. There are 0 homozygotes in GnomAd4. There are 33 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_152618.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BBS12
NM_152618.3
MANE Select
c.1859A>Gp.Gln620Arg
missense
Exon 2 of 2NP_689831.2
BBS12
NM_001178007.2
c.1859A>Gp.Gln620Arg
missense
Exon 3 of 3NP_001171478.1Q6ZW61

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BBS12
ENST00000314218.8
TSL:1 MANE Select
c.1859A>Gp.Gln620Arg
missense
Exon 2 of 2ENSP00000319062.3Q6ZW61
BBS12
ENST00000542236.5
TSL:2
c.1859A>Gp.Gln620Arg
missense
Exon 3 of 3ENSP00000438273.1Q6ZW61

Frequencies

GnomAD3 genomes
AF:
0.000460
AC:
70
AN:
152214
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000392
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000897
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000557
AC:
140
AN:
251288
AF XY:
0.000560
show subpopulations
Gnomad AFR exome
AF:
0.0000615
Gnomad AMR exome
AF:
0.000578
Gnomad ASJ exome
AF:
0.000298
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000942
Gnomad OTH exome
AF:
0.000815
GnomAD4 exome
AF:
0.000564
AC:
824
AN:
1461850
Hom.:
2
Cov.:
34
AF XY:
0.000576
AC XY:
419
AN XY:
727214
show subpopulations
African (AFR)
AF:
0.000119
AC:
4
AN:
33480
American (AMR)
AF:
0.000715
AC:
32
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.000689
AC:
18
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000301
AC:
26
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53388
Middle Eastern (MID)
AF:
0.00260
AC:
15
AN:
5768
European-Non Finnish (NFE)
AF:
0.000612
AC:
681
AN:
1112002
Other (OTH)
AF:
0.000795
AC:
48
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
53
105
158
210
263
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000460
AC:
70
AN:
152214
Hom.:
0
Cov.:
33
AF XY:
0.000444
AC XY:
33
AN XY:
74350
show subpopulations
African (AFR)
AF:
0.0000483
AC:
2
AN:
41446
American (AMR)
AF:
0.000392
AC:
6
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5198
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000897
AC:
61
AN:
68038
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.513
Heterozygous variant carriers
0
4
8
11
15
19
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000684
Hom.:
1
Bravo
AF:
0.000536
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00105
AC:
9
ExAC
AF:
0.000568
AC:
69
EpiCase
AF:
0.00164
EpiControl
AF:
0.00124

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
3
1
Bardet-Biedl syndrome 12 (4)
-
3
-
not provided (3)
-
1
-
Bardet-Biedl syndrome (1)
-
1
-
Bardet-Biedl syndrome 1 (1)
-
1
-
BBS12-related ciliopathy (1)
-
-
1
BBS12-related disorder (1)
-
1
-
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.095
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Benign
-0.23
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.069
T
Eigen
Uncertain
0.29
Eigen_PC
Uncertain
0.25
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Benign
0.62
T
M_CAP
Benign
0.027
D
MetaRNN
Benign
0.11
T
MetaSVM
Benign
-0.61
T
MutationAssessor
Uncertain
2.7
M
PhyloP100
4.1
PrimateAI
Benign
0.27
T
PROVEAN
Benign
-1.3
N
REVEL
Benign
0.22
Sift
Benign
0.031
D
Sift4G
Benign
0.062
T
Polyphen
0.93
P
Vest4
0.24
MVP
0.81
MPC
0.41
ClinPred
0.093
T
GERP RS
5.8
Varity_R
0.17
gMVP
0.28
Mutation Taster
=75/25
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs139278612; hg19: chr4-123664906; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.